Sustainable funding matters to the science
LinkedIn caption
🌱 Sustainable funding matters to the science
At ARDD 2026’s Early Stage Investor Panel, Chuen Yan Leung of Value Partners Group highlighted the damage inflated boom-time valuations can do to the longevity ecosystem. His advice in the official recap was practical: raise realistic amounts at disciplined valuations.
💡 That point sat within a wider discussion about developing therapies for specific diseases, choosing capital suited to drug-development timelines and delivering on milestones. For aging research to reach patients, the financing plan needs to support the long work of testing a credible therapeutic hypothesis.
#ARDD2026 #Biotech
X caption
🌱 Chuen Yan Leung of Value Partners Group brought funding discipline to #ARDD2026: realistic raises and credible valuations help longevity companies sustain the long path from a therapeutic hypothesis to patients. Disciplined financing gives research room to develop evidence.
Credit: Michael DeStefano
Copy and paste the caption manually, then attach the downloaded photo. Nothing is published automatically.
